Post Archive by Month

Reduction seen in cardiovascular events irrespective of baseline HbA1c or change in HbA1c

Counties without a cardiologist have higher cardiovascular risk index, higher cardiovascular mortality rates, and shorter life expectancy

Initiators of rivaroxaban or warfarin versus apixaban have significantly higher rates of major hemorrhage

Patients with overweight, obesity receiving tirzepatide significantly more likely to achieve ≥5, ≥10, and ≥15 percent weight loss

Risk for kidney failure with replacement therapy lower with ACEi, ARB treatment among individuals with advanced CKD

Pathology, psychiatry revenue experienced robust recovery by 2022; surgery, oncology revenue remained at or below baseline

94.7 percent of the acquisitions occurred during 2021 to 2023; acquisition less likely in highest poverty communities